{"id":"https://openalex.org/W4361849029","doi":"https://doi.org/10.1158/0008-5472.22418589.v1","title":"Supplementary Material 3 from Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells","display_name":"Supplementary Material 3 from Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361849029","doi":"https://doi.org/10.1158/0008-5472.22418589.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22418589.v1","doi":"https://doi.org/10.1158/0008-5472.22418589.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418589.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.22418589.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052419984","display_name":"Or\u2010Yam Revach","orcid":"https://orcid.org/0000-0002-1606-7467","observed_orcids":["https://orcid.org/0000-0002-1606-7467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Or-Yam Revach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1606-7467","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006124911","display_name":"Oded Sandler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oded Sandler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042139239","display_name":"Yardena Samuels","orcid":"https://orcid.org/0000-0002-3349-7266","observed_orcids":["https://orcid.org/0000-0002-3349-7266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yardena Samuels","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3349-7266","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046264807","display_name":"Benjamin Geiger","orcid":"https://orcid.org/0000-0001-8559-6373","observed_orcids":["https://orcid.org/0000-0001-8559-6373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Geiger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.45190000534057617,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.45190000534057617,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.2621999979019165,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axl","display_name":"AXL","score":0.7799999713897705},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8090000152587891},{"id":"https://openalex.org/keywords/gene-expression-clusters","display_name":"gene expression clusters","score":0.6850000023841858},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C200786668","wikidata":"https://www.wikidata.org/wiki/Q3498029","display_name":"Invadopodia","level":4,"score":0.8786223530769348},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6206058859825134},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.6079591512680054},{"id":"https://openalex.org/C172811965","wikidata":"https://www.wikidata.org/wiki/Q21110911","display_name":"GAS6","level":4,"score":0.5714737176895142},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5352806448936462},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.5127819180488586},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.45556023716926575},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.45132604241371155},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44685205817222595},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43323925137519836},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4315441846847534},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38581231236457825},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25399619340896606},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.24330130219459534},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17394274473190308},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.11176866292953491},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.22418589.v1","doi":"https://doi.org/10.1158/0008-5472.22418589.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418589.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22418589","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Material_3_from_Cross-Talk_between_Receptor_Tyrosine_Kinases_AXL_and_ERBB3_Regulates_Invadopodia_Formation_in_Melanoma_Cells/22418589","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22418589.v1","doi":"https://doi.org/10.1158/0008-5472.22418589.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22418589.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361834327","https://openalex.org/W2891207240","https://openalex.org/W4361848958","https://openalex.org/W1969717303","https://openalex.org/W3094964587","https://openalex.org/W4361282386","https://openalex.org/W2298005605","https://openalex.org/W2370368684","https://openalex.org/W2554327132","https://openalex.org/W2028550791"],"abstract_inverted_index":{"Statistics":[0],"for":[1,56,84],"gene":[2],"expression":[3,17,55,83],"analysis":[4],"(Figure":[5],"6A).":[6],"In":[7,32,59],"the":[8,26,33,51,60,66,79],"first":[9],"tab,":[10,35,62],"significant":[11,36,63],"levels":[12,37,64],"of":[13,38,54,65,82],"ERRB3":[14],"and":[15,25,46,74],"AXL":[16],"against":[18],"all":[19],"6":[20],"genes":[21,42,70],"(AXL,":[22],"ERBB3,":[23],"MITF3":[24],"3":[27],"targets)":[28],"in":[29,40,68],"each":[30,57,85],"cluster.":[31],"second":[34],"differences":[39,67],"invadopodia":[41],"between":[43,71],"Clusters":[44,72],"1":[45,73],"2,":[47,75],"as":[48,50,76,78],"well":[49,77],"delta":[52,80],"median":[53,81],"gene.":[58,86],"third":[61],"TK":[69]},"counts_by_year":[],"updated_date":"2026-09-04T10:56:28.161419","created_date":"2023-04-05T00:00:00"}